Ep 68 - What's next in Diabetes? CeQur moving toward manufacturing, Medtronic readying for the long haul

DeviceTalks Weekly

Jul 30 2021 | 01:19:57

00:00 / 01:19:57

Episode 68 • July 30, 2021 • 01:19:57

Hosted By

Show Notes

This week's episode focuses on new hope for people with diabetes. Brad Paddock, CEO of CeQur, explains how its "wearable pen" can deliver insulin in a better way while Sean Salmon, head of Medtronic's diabetes business, reviews that company's growing portfolio. He also gives insights on its intriguing partnership with the private equity group, Blackstone. Chris Newmarker, executive editor of life sciences, drops a weighty Newmarker's Newmakers featuring stories from Hillrom, Baxter, NeuroMetrix, Philips, Medtronic and BD. Subscribe to this podcast on all major podcast apps.

Ep 87 - Outset Medical’s Leslie Trigg explains how home-based dialysis can restore patients’ “sense of self”

In this week’s DeviceTalks Weekly podcast, Outset Medical’s Leslie Trigg recounts the career detour that led her to a successful career in medical devices....

Play

00:55:47

Ep 82 - Lobo and Pierce talk Wright, cool tech, robotics and the not-so-secret plans to keep Stryker growing

In this episode, we’ll do a deep dive with Stryker Corp., which recently hosted an in-person analyst day. In our first interview Andy Pierce,...

Play

01:16:20

Ep 52 - Earnhardt shares how Abbott shifted gears to counter pandemic; Grail still looks to upend oncology

This week, we’ll talk with Lisa Earnhardt, executive vice president, medical devices at Abbott about how the life sciences giant pivoted during the pandemic....

Play

01:04:33

Show Notes

Other Episodes

Ep 87 - Outset Medical’s Leslie Trigg explains how home-based dialysis can restore patients’ “sense of self”

Ep 82 - Lobo and Pierce talk Wright, cool tech, robotics and the not-so-secret plans to keep Stryker growing

Ep 52 - Earnhardt shares how Abbott shifted gears to counter pandemic; Grail still looks to upend oncology